Chemomab holder reports 5.2% passive stake

Chemomab Therapeutics Ltd. is reported to have a significant shareholder, Touchstone Global Investments Pty Ltd of Australia.

Rhea-AI Filing Summary

Chemomab Therapeutics Ltd. is reported to have a significant shareholder, Touchstone Global Investments Pty Ltd of Australia. Touchstone reports beneficial ownership of 377,814 American Depositary Shares (ADSs), each ADS representing 80 ordinary shares. This holding represents 5.2% of the outstanding ADSs of this class.

Touchstone reports sole voting power and sole dispositive power over all 377,814 ADSs, with no shared voting or dispositive power. The position is reported on a Schedule 13G, indicating a passive ownership filing status as of the reported date.

Key Figures

Beneficially owned ADSs: 377,814 ADSs Ownership percentage: 5.2% ADS to ordinary share ratio: 1 ADS = 80 ordinary shares +2 more

5 metrics

Beneficially owned ADSs 377,814 ADSs ADSs of Chemomab Therapeutics beneficially owned by Touchstone Global Investments

Ownership percentage 5.2% Percent of Chemomab Therapeutics ADS class held by Touchstone Global Investments

ADS to ordinary share ratio 1 ADS = 80 ordinary shares Each American Depositary Share represents 80 ordinary shares, no par value

Sole voting power 377,814 ADSs ADSs over which Touchstone Global Investments has sole power to vote

Sole dispositive power 377,814 ADSs ADSs over which Touchstone Global Investments has sole power to dispose

Key Terms

beneficially owned, Sole Voting Power, Sole Dispositive Power, American Depositary Shares, +1 more

5 terms

beneficially owned financial

"Amount beneficially owned: 377814 ADSs"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole Voting Power financial

"Sole Voting Power 377,814.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"Sole Dispositive Power 377,814.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

American Depositary Shares financial

"Title of class of securities: American Depositary Shares, each"

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

Schedule 13G regulatory

"form_type: "SCHEDULE 13G""

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What percentage of Chemomab Therapeutics (CMMB) does Touchstone Global Investments own?

Touchstone Global Investments reports beneficial ownership of 5.2% of Chemomab Therapeutics’ ADSs. This stake is disclosed on a Schedule 13G, indicating a passive ownership position based on current shareholdings.

How many Chemomab Therapeutics (CMMB) ADSs does Touchstone Global Investments hold?

Touchstone Global Investments reports holding 377,814 American Depositary Shares (ADSs) of Chemomab Therapeutics. Each ADS represents 80 ordinary shares, giving Touchstone voting and dispositive power over this ADS amount.

Does Touchstone Global Investments have sole voting power over its Chemomab (CMMB) shares?

Yes. Touchstone Global Investments reports sole voting power over 377,814 ADSs of Chemomab Therapeutics and no shared voting power, meaning it alone can direct the vote for those ADSs.

What dispositive power does Touchstone Global Investments report over Chemomab (CMMB) ADSs?

Touchstone Global Investments reports sole dispositive power over 377,814 ADSs of Chemomab Therapeutics and no shared dispositive power, indicating it alone can decide if and when to sell or transfer those ADSs.

Is the Chemomab (CMMB) ownership filing by Touchstone Global Investments a Schedule 13G or 13D?

The ownership is reported on a Schedule 13G. This form is typically used for passive holders that exceed the 5% threshold, rather than for investors seeking to influence control via a Schedule 13D.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 08:38 AM Accepted by SEC EDGAR 08/13/2026 - 08:38 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Chemomab Therapeutics Ltd.

(Name of Issuer)

American Depositary Shares, each representing 80 Ordinary Shares, no par value

(Title of Class of Securities)

16385C203

(CUSIP Number)

08/07/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 16385C203

1

Names of Reporting Persons

Touchstone Global Investments Pty Ltd

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

AUSTRALIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 377,814.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 377,814.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

377,814.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.2 %

12

Type of Reporting Person (See Instructions)

CO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Chemomab Therapeutics Ltd.
(b)	Address of issuer's principal executive offices: KIRYAT ATIDIM, BUILDING 7, TEL AVIV, ISRAEL, 6158101
Item 2.
(a)	Name of person filing: Touchstone Global Investments Pty Ltd
(b)	Address or principal business office or, if none, residence: Level 5, 100 Flinders Street, Melbourne, VIC 3101, Australia
(c)	Citizenship: Australia
(d)	Title of class of securities: American Depositary Shares, each representing 80 Ordinary Shares, no par value
(e)	CUSIP Number(s): 16385C203
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 377814 ADSs
(b)	Percent of class: 5.2%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 377814 ADSs
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 377814 ADSs
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Touchstone Global Investments Pty Ltd

Signature:	Mathew Browning
Name/Title:	Director
Date:	08/13/2026